Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study

International Journal of Geriatric Psychiatry ◽

10.1002/gps.859 ◽

2003 ◽

Vol 18 (6) ◽

pp. 549-551 ◽

Author(s):

V. P. Prasher ◽

C. Adams ◽

R. Holder ◽

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Down Syndrome ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease: final analysis of a US multicentre open-label study

European Neuropsychopharmacology ◽

10.1016/s0924-977x(00)00067-5 ◽

2000 ◽

Vol 10 (3) ◽

pp. 195-203 ◽

Author(s):

S.L Rogers ◽

R.S Doody ◽

R.D Pratt ◽

J.R Ieni

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Final Analysis ◽

Efficacy And Safety ◽

Open Label Study ◽

Label Study ◽

Download Full-text

Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study

Current Medical Research and Opinion ◽

10.1185/030079904125004204 ◽

2004 ◽

Vol 20 (10) ◽

pp. 1605-1612 ◽

Author(s):

Peter M. Aupperle ◽

Barbara Koumaras ◽

Michael Chen ◽

Adrian Rabinowicz ◽

Dario Mirski

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Nursing Home ◽

Nursing Home Residents ◽

Long Term Effects ◽

Behavioral Disturbances ◽

Open Label Study ◽

Download Full-text

Safety and Efficacy of 10 kHz Spinal Cord Stimulation for the Treatment of Refractory Chronic Migraine: A Prospective Long‐Term Open‐Label Study

Neuromodulation Technology at the Neural Interface ◽

10.1111/ner.13465 ◽

2021 ◽

Author(s):

Adnan Al‐Kaisy ◽

Stefano Palmisani ◽

Roy Carganillo ◽

Samuel Wesley ◽

David Pang ◽

...

Keyword(s):

Spinal Cord ◽

Chronic Migraine ◽

Spinal Cord Stimulation ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Refractory Chronic Migraine

Download Full-text

A long-term, open-label study of the safety and efficacy of oral tazarotene in moderate to very severe plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2003.10.012 ◽

2004 ◽

Vol 50 (3) ◽

pp. P2 ◽

Author(s):

Alan Menter ◽

Deborah Lew-Kaya ◽

Frederick Beddingfield ◽

Patricia S. Walker

Keyword(s):

Plaque Psoriasis ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Severe Plaque Psoriasis

Download Full-text

Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: A 26-week, multicenter, open-label study

The American Journal of Geriatric Pharmacotherapy ◽

10.1016/s1543-5946(05)80020-0 ◽

2005 ◽

Vol 3 (3) ◽

pp. 137-148 ◽

Author(s):

Jeffrey L. Cummings ◽

Barbara Koumaras ◽

Michael Chen ◽

Dario Mirski

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Nursing Home ◽

Nursing Home Residents ◽

Behavioral Disturbances ◽

Open Label Study ◽

Download Full-text

Brain stimulation by pulsed electromagnetic fields in the treatment of Alzheimer's disease: An open-label study

European Journal of Integrative Medicine ◽

10.1016/j.eujim.2016.08.015 ◽

2016 ◽

Vol 8 ◽

pp. 5-6

Author(s):

Fabio Guerriero ◽

Piero Mannu ◽

Gianni Mele ◽

Zoncu D ◽

Lorenzo Polo ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Electromagnetic Fields ◽

Brain Stimulation ◽

Pulsed Electromagnetic Fields ◽

Open Label Study ◽

Label Study ◽

Pulsed Electromagnetic

Download Full-text

A 52-week open-label study to investigate tolerability of rivastigmine switching from oral capsule to transdermal patch in mild to moderate Alzheimer’s disease patients in Taiwan

Journal of the Neurological Sciences ◽

10.1016/j.jns.2017.08.2909 ◽

2017 ◽

Vol 381 ◽

pp. 1030-1031

Author(s):

J.L. Fuh ◽

T.F. Chen ◽

T.H. Lan ◽

Y.W. Yang ◽

C.F. Tsai ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Transdermal Patch ◽

Open Label Study ◽

Label Study ◽

Download Full-text

Long-Term Safety and Efficacy of Donepezil in Patients with Severe Alzheimer’s Disease: Results from a 52-Week, Open-Label, Multicenter, Extension Study in Japan

Dementia and Geriatric Cognitive Disorders ◽

10.1159/000203887 ◽

2009 ◽

Vol 27 (3) ◽

pp. 232-239 ◽

Author(s):

Akira Homma ◽

Yukimichi Imai ◽

Hisao Tago ◽

Takashi Asada ◽

Masahiro Shigeta ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Extension Study ◽

Safety And Efficacy

Download Full-text

Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine

Geriatrics and Gerontology International ◽

10.1111/ggi.12754 ◽

2016 ◽

Vol 17 (3) ◽

pp. 494-499 ◽

Author(s):

Soo J Yoon ◽

Seong H Choi ◽

Hae R Na ◽

Kyung-Won Park ◽

Eun-Joo Kim ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Combination Therapy ◽

Open Label Study ◽

Label Study ◽

Rivastigmine Patch

Download Full-text

PRISM II: An Open-Label Study to Assess the Safety, Tolerability, and Effectiveness of Dextromethorphan 20 mg/Quinidine 10 mg for Treatment of Pseudobulbar Affect Secondary to Dementia, Stroke, or Traumatic Brain Injury: Results from the Alzheimer's Disease/Dementia Cohort

American Journal of Geriatric Psychiatry ◽

10.1016/j.jagp.2014.12.170 ◽

2015 ◽

Vol 23 (3) ◽

pp. S163-S164

Author(s):

Rachelle S. Doody ◽

Stephen D'Amico ◽

Andrew J. Cutler ◽

Paul Shin ◽

Frederic Ledon ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Traumatic Brain Injury ◽

Brain Injury ◽

Open Label Study ◽

Label Study ◽

Pseudobulbar Affect ◽

Alzheimer’S Disease Dementia

Download Full-text